查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485800

神經生物標記市場的免疫測定，依疾病類型、副產品、最終用戶、技術、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Immunoassay for Neurological Biomarkers Market, By Disease Type, By Product, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 397 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年神經生物標記免疫測定市場規模為 7.0767 億美元，2024 年至 2032 年複合年成長率為 17.5%。

神經生物標記市場的免疫分析-市場動態

神經和精神疾病病例不斷增加

神經生物標記免疫分析市場在神經和精神疾病的檢測和診斷中發揮重要作用。免疫測定可以及早檢測與阿茲海默症、帕金森氏症、多發性硬化症等各種疾病相關的神經生物標記。早期檢測有助於早期介入和治療，有可能減緩疾病進展並改善患者預後。據世界衛生組織 (WHO) 稱，全球有超過 30 億人因疾病和殘疾而患有神經系統疾病。此外，超過 80% 的神經系統死亡發生在低收入和中等收入國家。

神經生物標記市場的免疫測定 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 17.5% 左右的複合年成長率成長

根據疾病類型區隔，阿茲海默症預計將在 2023 年佔據最大市場佔有率

從技術區隔來看，放射免疫分析（RIA）是2023年的主導類型

根據最終用戶區隔，2023年醫院是領先類型

依地區分類，北美是 2023 年的主要收入來源

神經生物標記免疫測定市場區隔分析：

全球神經生物標記免疫測定市場根據疾病類型、產品、最終用戶、技術和地區進行區隔。

根據疾病類型，市場分為六類： 生物標記免疫測定可以在臨床症狀出現之前及早發現 AD。免疫測定廣泛用於旨在開發 AD 新療法的臨床試驗。它們幫助研究人員衡量實驗治療對生物標記水平的影響，並評估其潛在功效和安全性。

根據最終用戶，市場分為六類： 神經生物標記的免疫測定廣泛用於醫院，用於與神經系統疾病的診斷、預後和監測相關的各種目的。例如，某些生物標記的水平可能表明疾病的嚴重程度或進展，幫助臨床醫生預測疾病可能的病程並規劃適當的治療策略。

神經生物標記市場的免疫測定 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

就免疫分析神經生物標記市場的收入而言，北美擁有全球最大的市場佔有率。這是由於更好的政府措施和強勁的經濟。由於分子診斷的使用不斷增加，美國是該市場的領導者。在歐洲，由於競爭加劇和人們意識的提高，市場正在成長。利害關係人對涉及蛋白質、相關生物分子和基因的研究項目的關注是推動歐洲神經免疫分析市場成長的關鍵因素。

神經生物標記免疫分析市場-競爭格局：

由於市場參與者採取的各種策略性舉措，用於神經生物標記的免疫測定市場正在迅速擴大。這些措施包括開發用於診斷和治療研究的先進生物標記技術。例如，2022 年12 月，美國FDA 批准了F. Hoffmann-La Roche Ltd 開發的兩種免疫測定法。 42) CSF II （Abeta42）。這些測定可用於測量成年患者的兩種重要生物標記：tau 蛋白和 BETA-澱粉樣蛋白。它們有助於確認阿茲海默症的診斷。

最近的發展：

2024 年 2 月，Abbott 和 Fujirebio 宣布合作開發僅供研究使用的神經絲輕鏈 (NfL) 測試。神經學生物標記檢測將可在 Abbott 的 Alinity I 儀器上使用，並且還將提供給進行研究的研究人員，以證明 NfL 生物標記的實用性。

2023 年 3 月，HU Group Holdings Inc. 及其子公司 Fujirebio 宣布發布兩種用於 LUMIPULSE G 免疫分析系統的新檢測方法：Lumipulse G NfL CSF 和 Lumipulse G NfL Blood。這些 CLEIA 檢測能夠分別準確測量人類腦脊髓液 (CSF) 和血漿/血清中的神經絲光 (NfL)。

目錄

第 1 章：神經生物標記免疫分析市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 神經生物標記免疫測定市場片段（依疾病類型）
    • 神經生物標記免疫測定市場片段（依產品）
    • 最終用戶的神經生物標記免疫測定市場片段
    • 神經生物標記免疫分析市場片段（依技術）
    • 神經生物標記免疫測定市場片段（依國家/地區）
    • 神經生物標記免疫測定市場片段（依地區）
  • 競爭洞察

第 3 章：神經生物標記的免疫測定主要市場趨勢

  • 神經生物標記市場促進因素的免疫測定
    • 市場促進因素的影響分析
  • 神經生物標記市場限制的免疫分析
    • 市場限制影響分析
  • 神經生物標記免疫分析市場機會
  • 神經生物標記免疫分析市場未來趨勢

第 4 章：神經生物標記免疫測定產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：神經生物標記市場的免疫測定：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：神經生物標記免疫測定市場格局

  • 神經生物標記免疫分析市佔率分析，2023 年
  • 依主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：神經生物標記市場的免疫分析 - 依疾病類型

  • 概述
    • 依疾病類型分類的區隔市場佔有率分析
    • 阿茲海默氏症
    • 帕金森氏症
    • 亨丁頓舞蹈症
    • 肌萎縮側索硬化症 (ALS)
    • 脊髓性肌肉萎縮症 (SMA)
    • 其他

第 8 章：神經生物標記市場的免疫分析 - 副產品

  • 概述
    • 依產品分類的區隔市場佔有率分析
    • 儀器
    • 試劑
    • 服務

第 9 章：神經生物標記市場的免疫分析 - 由最終用戶

  • 概述
    • 依最終用戶分類的區隔市場佔有率分析
    • 醫院
    • 診所
    • 學術組織
    • 生物製藥公司
    • 製藥公司
    • 其他

第 10 章：神經生物標記市場的免疫分析 - 依技術

  • 概述
    • 依技術分類的區隔市場佔有率分析
    • 放射免疫分析 (RIA)
    • 聚合酶鍊式反應 (PCR)
    • 酵素連結免疫吸附試驗
    • 蛋白質印跡
    • 快速測試
    • 酵素連結免疫斑點法

第 11 章：神經生物標記市場的免疫分析 - 依地理位置

  • 介紹
    • 依地理位置分類的區隔市場佔有率分析
  • 北美洲
    • 概述
    • 神經生物標記免疫測定北美主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依疾病類型）
    • 北美市場規模和預測（依產品）
    • 北美市場規模和預測（依最終用戶）
    • 北美市場規模和預測（依技術）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 神經生物標記免疫測定歐洲主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依疾病類型）
    • 歐洲市場規模和預測（依產品）
    • 歐洲市場規模和預測（依最終用戶）
    • 歐洲市場規模與預測（依技術）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 神經生物標記免疫測定亞太地區主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依疾病類型）
    • 亞太地區市場規模與預測（依產品）
    • 亞太地區市場規模和預測（依最終用戶）
    • 亞太地區市場規模與預測（依技術）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 神經生物標記免疫測定拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依疾病類型）
    • 拉丁美洲市場規模與預測（依產品）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 拉丁美洲市場規模與預測（依技術）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 神經生物標記免疫測定中東和非洲主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依疾病類型）
    • 中東和非洲市場規模及預測（依產品）
    • 中東和非洲市場規模及預測（依最終用戶）
    • 中東和非洲市場規模及預測（依技術）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 神經生物標記產業的免疫測定

  • 競爭儀表板
  • 公司簡介
    • QIAGEN
    • Abbott
    • Merck & Co., Inc.
    • Johnson & Johnson Services, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • Merck KGaA
    • F. Hoffmann La-Roche Ltd.
    • Nimble Therapeutics
    • ADx NeuroSciences NV
    • Enrolmmun
    • ACOBIOM
    • Banyan Biomarkers Inc.
    • Olink Biosciences
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2703

REPORT HIGHLIGHT

Immunoassay for Neurological Biomarkers Market size was valued at USD 707.67 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.

Immunoassays for neurological biomarkers are laboratory techniques used to measure the levels of certain molecules in biological samples, such as blood or cerebrospinal fluid, that are indicative of neurological conditions or diseases. The rising prevalence of neurological disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis creates a growing need for reliable biomarkers for early diagnosis, prognosis, and monitoring of disease progression. However, the market is facing some regulatory approval for new biomarkers and immunoassays which can be a lengthy and costly process, hindering the translation of research findings into clinically useful diagnostics. Furthermore, there is a growing emphasis on the development of biomarkers for early diagnosis and monitoring of neurological diseases, creating opportunities in future.

Immunoassay for Neurological Biomarkers Market- Market Dynamics

Rising cases of neurological and psychiatric disorders

The Immunoassay for Neurological Biomarkers market plays a significant role in the detection and diagnosis of neurological and psychiatric disorders. Immunoassays allow for the early detection of neurological biomarkers associated with various disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Early detection enables early intervention and treatment, potentially slowing down disease progression and improving patient outcomes. According to the World Health Organization (WHO), more than 3 billion people worldwide are living with a neurological condition due to illness & disability. In addition, over 80% of neurological deaths occur in low- and middle-income countries.

Immunoassay for Neurological Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)

Based on disease type segmentation, Alzheimer's disease was predicted to show maximum market share in the year 2023

Based on technology segmentation, radioimmunoassays (RIA) was the leading type in 2023

Based on end user segmentation, hospitals were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:

The Global Immunoassay for Neurological Biomarkers Market is segmented based on Disease Type, Product, End User, Technology, and Region.

The market is divided into six categories based on disease type: Biomarker immunoassays enable early detection of AD even before clinical symptoms appear. Immunoassays are widely used in clinical trials aimed at developing new therapies for AD. They help researchers measure the impact of experimental treatments on biomarker levels and assess their potential efficacy and safety.

The market is divided into six categories based on end user: Immunoassays for neurological biomarkers are widely used in hospitals for various purposes related to the diagnosis, prognosis, and monitoring of neurological disorders. For instance, levels of certain biomarkers might indicate the severity or progression of a disease, helping clinicians predict the likely course of the illness and plan appropriate treatment strategies.

Immunoassay for Neurological Biomarkers Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America has the largest market share in terms of revenue across the world for the immunoassay neurological biomarkers market. This is due to better government initiatives and a strong economy. The United States is a leader in this market, driven by the increasing use of molecular diagnosis. In Europe, the market is growing due to rising competition and increased awareness among the population. The stakeholders' focus on research projects involving proteins, associated biomolecules, and genes are the key factors driving the growth of the neuro immunoassay market in Europe.

Immunoassay for Neurological Biomarkers Market- Competitive Landscape:

The market for immunoassays used for neurological biomarkers is expanding rapidly due to various strategic initiatives taken by market players. These initiatives include the development of advanced biomarker technology for diagnostic and treatment research. For instance, in December 2022, the United States FDA approved two immunoassays developed by F. Hoffmann-La Roche Ltd. These immunoassays are Elecsys Phospho-Tau (181P) CSF (pTau181) and Elecsys beta-Amyloid (1-42) CSF II (Abeta42). These assays are useful for measuring two important biomarkers, tau proteins, and beta-amyloid, in adult patients. They aid in the confirmation of Alzheimer's disease diagnosis.

Recent Developments:

In February 2024, Abbott and Fujirebio announced partnering to develop a research-use-only test for the neurofilament-light chain (NfL). The neurology biomarker assay will be available for use on Abbott's Alinity I instrument and also will be offered to researchers conducting studies demonstrating the utility of the NfL biomarker.

In March 2023, H.U. Group Holdings Inc. and its subsidiary, Fujirebio, announced the release of two new assays, Lumipulse G NfL CSF and Lumipulse G NfL Blood, for LUMIPULSE G immunoassay systems. These CLEIA assays enable the accurate measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Abbott

Merck & Co., Inc.

Johnson & Johnson Services, Inc.

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Sysmex Corporation

Merck KGaA

F. Hoffmann La-Roche Ltd.

Nimble Therapeutics

ADx NeuroSciences NV

Enrolmmun

ACOBIOM

Banyan Biomarkers Inc.

Olink Biosciences

Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Alzheimer's Disease
  • Parkinson's Disease
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis (ALS)
  • Spinal Muscular Atrophy (SMA)
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents
  • Services

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Academic Organizations
  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Radioimmunoassays (RIA)
  • Polymerase Chain Reaction (PCR)
  • ELISA
  • Western Blot
  • Rapid Tests
  • ELISPOT

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Immunoassay For Neurological Biomarkers Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Immunoassay For Neurological Biomarkers Market Snippet by Disease Type
    • 2.1.2.Immunoassay For Neurological Biomarkers Market Snippet by Product
    • 2.1.3.Immunoassay For Neurological Biomarkers Market Snippet by End User
    • 2.1.4.Immunoassay For Neurological Biomarkers Market Snippet by Technology
    • 2.1.5.Immunoassay For Neurological Biomarkers Market Snippet by Country
    • 2.1.6.Immunoassay For Neurological Biomarkers Market Snippet by Region
  • 2.2.Competitive Insights

3.Immunoassay For Neurological Biomarkers Key Market Trends

  • 3.1.Immunoassay For Neurological Biomarkers Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Immunoassay For Neurological Biomarkers Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Immunoassay For Neurological Biomarkers Market Opportunities
  • 3.4.Immunoassay For Neurological Biomarkers Market Future Trends

4.Immunoassay For Neurological Biomarkers Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Immunoassay For Neurological Biomarkers Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Immunoassay For Neurological Biomarkers Market Landscape

  • 6.1.Immunoassay For Neurological Biomarkers Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Immunoassay For Neurological Biomarkers Market - By Disease Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 7.1.2.Alzheimer's Disease
    • 7.1.3.Parkinson's Disease
    • 7.1.4.Huntington's Disease
    • 7.1.5.Amyotrophic Lateral Sclerosis (ALS)
    • 7.1.6.Spinal Muscular Atrophy (SMA)
    • 7.1.7.Others

8.Immunoassay For Neurological Biomarkers Market - By Product

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2.Instruments
    • 8.1.3.Reagents
    • 8.1.4.Services

9.Immunoassay For Neurological Biomarkers Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Clinics
    • 9.1.4.Academic Organizations
    • 9.1.5.Biopharmaceutical Companies
    • 9.1.6.Pharmaceutical Companies
    • 9.1.7.Others

10.Immunoassay For Neurological Biomarkers Market - By Technology

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 10.1.2.Radioimmunoassays (RIA)
    • 10.1.3.Polymerase Chain Reaction (PCR)
    • 10.1.4.ELISA
    • 10.1.5.Western Blot
    • 10.1.6.Rapid Tests
    • 10.1.7.ELISPOT

11.Immunoassay For Neurological Biomarkers Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Immunoassay For Neurological Biomarkers Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Immunoassay For Neurological Biomarkers Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.QIAGEN
    • 12.2.2.Abbott
    • 12.2.3.Merck & Co., Inc.
    • 12.2.4.Johnson & Johnson Services, Inc.
    • 12.2.5.Thermo Fisher Scientific, Inc.
    • 12.2.6.Bio-Rad Laboratories, Inc.
    • 12.2.7.Sysmex Corporation
    • 12.2.8.Merck KGaA
    • 12.2.9.F. Hoffmann La-Roche Ltd.
    • 12.2.10.Nimble Therapeutics
    • 12.2.11.ADx NeuroSciences NV
    • 12.2.12.Enrolmmun
    • 12.2.13.ACOBIOM
    • 12.2.14.Banyan Biomarkers Inc.
    • 12.2.15.Olink Biosciences
    • 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immunoassay For Neurological Biomarkers Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Product 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by End User 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Technology 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)